Scientists discover hidden structure of enigmatic ‘backwards’ neural connections 17 April 2018 | By Drug Target Review Scientists reveal the existence of dense connections in the brain...
Man-made antibodies show promise in attacking cancer cells in animal models 17 April 2018 | By Dr Zara Kassam (Drug Target Review) Molecules called aptamers could form new, safer chemotherapy delivery systems...
SMi’s 13th Annual ADMET conference 2018 brochure released 17 April 2018 | By SMi Group The annual ADMET conference is returning to London, UK for its 13th year running and will be taking place at the Holiday Inn Kensington Forum on the 9 and 10 July 2018...
Contrast-enhanced subharmonic imaging detects prostate cancers 16 April 2018 | By Dr Zara Kassam (Drug Target Review) A test of contrast-enhanced subharmonic imaging has shown promise in detecting prostate cancers that were not identified by MRI...
Blood test may predict future risk of cardiovascular events 16 April 2018 | By Dr Zara Kassam (Drug Target Review) A study of 27,000 women finds that branched-chain amino acid levels in the bloodstream are as predictive of heart disease as LDL cholesterol, other risk factors...
Nanoparticles shown to be effective in treating NSCLC 16 April 2018 | By Dr Zara Kassam (Drug Target Review) Non-small cell lung cancer Nanoparticles pass the next stage of development in preclinical tests...
The European Life Sciences Community meets at BASEL LIFE 13 April 2018 | By BASEL Life Science Leading experts of the European Life Sciences Community are engaging under the name BASEL LIFE to establish a bridge between science and business.
Biomarkers may help provide personalised treatment for brain cancer 13 April 2018 | By Drug Target Review Researchers in Brazil have identified seven biomarkers that could be used to indicate which glioma patients are likely to experience an aggressive form of the brain cancer.
Study reveals every bowel tumour and bowel cancer cell have unique genetic fingerprints 13 April 2018 | By Drug Target Review Single-cell technology and organoids enable researchers to study cancer-specific processes...
Disrupting macrophage action aids melanoma immunotherapy success 13 April 2018 | By Drug Target Review Scientists in Switzerland have uncovered a potential means of increasing effective treatment of melanomas with immunotherapy, by disrupting the action of macrophages.
New class of drugs could help tackle treatment-resistant cancers 12 April 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies...
KLF14 gene may increase risk of type 2 diabetes 12 April 2018 | By Drug Target Review Scientists have identified a gene that in women is linked to the creation and location of new fat cells and therefore is thought to contribute to the risk of type 2 diabetes...
Sensitive new assay detects hepatitis B infection in single liver cells and serum 12 April 2018 | By Dr Zara Kassam (Drug Target Review) Technique measuring the cccDNA marker may allow earlier detection of hepatocellular carcinoma in patients...
Rare brain disease in children: Major breakthroughs in Rasmussen’s encephalitis 11 April 2018 | By Dr Zara Kassam (Drug Target Review) Chronic focal encephalitis is a rare and devastating inflammatory brain disease, researchers have proven that the disease attacks patients using their own immune system...
Cryo-electron microscopy reveals structure of a herpesvirus capsid 11 April 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have reconstructed the 3.1 Å structure of the herpes simplex virus type 2 (HSV-2) B-capsid and built the atomic model, thus expanding the understanding of the assembly mechanism of the capsid...
